fda sued over tirzepatide FDA's decision creates uncertainty for patients—and leads to a lawsuit FDA's Removal of Semaglutide and

As was the case with Saxenda, Wegovy is indicated as a weight-loss medication in conjunction with diet and exercise

Considerations Before Enrolling Compounded medications are not FDA-approved, though prepared in FDA-regulated pharmacies

Side Effects Timeline: What to Expect Most people follow a similar adjustment pattern: Weeks 12 nausea, appetite suppression, mild fatigue Weeks 36 symptoms stabilize Weeks 6+ improved tolerance for most patients Dose increases can temporarily bring symptoms back, but they usually fade again

The primary endpoint was to demonstrate non-inferiority (with a non-inferiority margin of 0.3%) of tirzepatide 10 mg or 15 mg, or both, compared to glargine in terms of the change in HbA1c from baseline to 52 weeks

Often, small adjustments to your diet can make the weekly injection much more comfortable